No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
COLL Collegium Pharmaceutical
- 34.180
- -0.320-0.93%
Close May 22 16:00 ET
1.12BMarket Cap13.62P/E (TTM)
34.820High34.030Low274.09KVolume34.520Open34.500Pre Close9.41MTurnover0.90%Turnover Ratio26.50P/E (Static)32.72MShares40.95052wk High5.03P/B1.04BFloat Cap20.83052wk Low--Dividend TTM30.39MShs Float40.950Historical High--Div YieldTTM2.29%Amplitude7.370Historical Low34.333Avg Price1Lot Size
Pre-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Collegium Pharmaceutical(COLL.US) Director Sells US$936.31K in Common Stock
$Collegium Pharmaceutical(COLL.US)$ Director BOHLIN GAREN G sold 28,985 shares of common stock on May 14, 2024 at an average price of $32.3033 for a total value of $936.31K.Source: Announcement What i
Form 144 | Collegium Pharmaceutical(COLL.US) Director Proposes to Sell 936.31K in Common Stocks
SEC FILLINGS DISCLOSED/ May 14, $Collegium Pharmaceutical(COLL.US)$ Director BOHLIN GAREN G intends to sell 28,985 shares of its common stock on May 14, with a total market value of approximately $936
Collegium Pharmaceutical Enters ASR Agreement To Repurchase $35 Mln Of Common Stock
Express News | Collegium Announces $35 Million Accelerated Share Repurchase Program
Collegium Downgraded by Piper Sandler Over Valuation
Sweetgreen, Natera Rise; Collegium Pharmaceutical, Akamai Fall, 5/10/2024
Comments
Collegium Pharmaceutical's low ROE, despite high debt, reflects negatively on its profitability. The firm's reliance on hefty debt to boost returns poses potential risks.
Can Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Improve Its Returns? 1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg